HUENENBERG, Switzerland — The Centers for Medicare and Medicaid Services has approved the inclusion of Alcon's AcrySof IQ toric IOL in the Reduced Spherical Aberration class of New Technology ...

Alcon Vivity Registry continues to demonstrate excellent outcomes with AcrySof IQ Vivity and AcrySof IQ Vivity Toric, the first and only PCIOL + with wavefront-shaping technology; World-renowned ...

A prospective comparative case series of 50 patients implanted bilaterally with either the toric or non-toric version of the AcrySof IQ PanOptix aspheric quadrifocal IOL from Alcon showed ...

The unique optical design of the ACTIVEFOCUS (TM) toric IOL gives astigmatic cataract patients quality distance vision and an increased range of vision to potentially reduce dependence on glasses ...

A-C IOLs – Acrysof Toric IOL (models: SN60T3, SN60T4, and SN60T5) and Acrysof IQ Toric IOL (models: SN6AT3, SN6AT4, and SN6AT5; collectively referred to as SN6ATT) manufactured by Alcon Laboratories. ...

Available in spherical and toric designs, PanOptix is built on Alcon’s proven AcrySof IQ IOL platform that has been implanted in more than 120 million eyes globally.

(RTTNews) - Alcon, a division of Novartis, announced it has received approval from the US FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with ACTIVEFOCUS optical design for ...

TORONTO, Nov. 17, 2020 /CNW/ - Alcon, the global leader in eye care, is pleased to announce the Canadian launch of AcrySof ® IQ Vivity ®, a first-of-its-kind, surgical lens designed to help ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its plans to lead a wide-range of informational and peer-to-peer educational programs at the ...

Alcon, the global leader in eye care, today announced the Food and Drug Administration approval and its initial commercial launch of AcrySof ® IQ PanOptix ® Trifocal Intraocular Lens, the first ...